A Kinetic Model of Antigen‐Dependent IgG Oligomerization and Complement Binding
The classical complement pathway (CCP) is an essential part of the immune system, activated when complement protein C1 binds to IgG antibody oligomers on the surface of pathogens, infected or malignant cells, culminating in the formation of the membrane attack complex and subsequent cell lysis. IgG...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley-VCH
2025-07-01
|
| Series: | Small Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/smsc.202500149 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839633619978551296 |
|---|---|
| author | Jürgen Strasser Nikolaus Frischauf Lukas Schustereder Andreas Karner Sieto Bosgra Aran F. Labrijn Frank J. Beurskens Johannes Preiner |
| author_facet | Jürgen Strasser Nikolaus Frischauf Lukas Schustereder Andreas Karner Sieto Bosgra Aran F. Labrijn Frank J. Beurskens Johannes Preiner |
| author_sort | Jürgen Strasser |
| collection | DOAJ |
| description | The classical complement pathway (CCP) is an essential part of the immune system, activated when complement protein C1 binds to IgG antibody oligomers on the surface of pathogens, infected or malignant cells, culminating in the formation of the membrane attack complex and subsequent cell lysis. IgG oligomers also engage immune effector cells through Fcγ receptors or complement receptors, facilitating antibody‐dependent cellular cytotoxicity and phagocytosis. Understanding the factors that drive IgG oligomerization is thus crucial for improving IgG‐based therapies. Herein, a kinetic model to predict oligomer formation based on IgG concentration, antigen density, IgG subclass, Fc mutants, and oligomerization inhibitors like staphylococcal protein A is developed. The underlying molecular interactions in single molecule force spectroscopy and grating coupled interferometry experiments are characterized. By fitting experimental data from high‐speed atomic force microscopy experiments, key rate constants and thermodynamic parameters, including free energy changes associated with oligomerization and apply the model to predict complement‐mediated lysis in liposomal vesicle‐based assays, are further quantified. The presented mechanistic framework may serve as a basis for optimizing antibody engineering and pharmacokinetic/pharmacodynamic modeling in the context of immunotherapies exploiting the CCP. |
| format | Article |
| id | doaj-art-68ef45d6f68f44ed82e7473af8e8fde1 |
| institution | Matheson Library |
| issn | 2688-4046 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Wiley-VCH |
| record_format | Article |
| series | Small Science |
| spelling | doaj-art-68ef45d6f68f44ed82e7473af8e8fde12025-07-11T03:29:45ZengWiley-VCHSmall Science2688-40462025-07-0157n/an/a10.1002/smsc.202500149A Kinetic Model of Antigen‐Dependent IgG Oligomerization and Complement BindingJürgen Strasser0Nikolaus Frischauf1Lukas Schustereder2Andreas Karner3Sieto Bosgra4Aran F. Labrijn5Frank J. Beurskens6Johannes Preiner7NASAN University of Applied Sciences Upper Austria 4020 Linz AustriaNASAN University of Applied Sciences Upper Austria 4020 Linz AustriaNASAN University of Applied Sciences Upper Austria 4020 Linz AustriaNASAN University of Applied Sciences Upper Austria 4020 Linz AustriaGenmab 3584 CT Utrecht NetherlandsGenmab 3584 CT Utrecht NetherlandsGenmab 3584 CT Utrecht NetherlandsNASAN University of Applied Sciences Upper Austria 4020 Linz AustriaThe classical complement pathway (CCP) is an essential part of the immune system, activated when complement protein C1 binds to IgG antibody oligomers on the surface of pathogens, infected or malignant cells, culminating in the formation of the membrane attack complex and subsequent cell lysis. IgG oligomers also engage immune effector cells through Fcγ receptors or complement receptors, facilitating antibody‐dependent cellular cytotoxicity and phagocytosis. Understanding the factors that drive IgG oligomerization is thus crucial for improving IgG‐based therapies. Herein, a kinetic model to predict oligomer formation based on IgG concentration, antigen density, IgG subclass, Fc mutants, and oligomerization inhibitors like staphylococcal protein A is developed. The underlying molecular interactions in single molecule force spectroscopy and grating coupled interferometry experiments are characterized. By fitting experimental data from high‐speed atomic force microscopy experiments, key rate constants and thermodynamic parameters, including free energy changes associated with oligomerization and apply the model to predict complement‐mediated lysis in liposomal vesicle‐based assays, are further quantified. The presented mechanistic framework may serve as a basis for optimizing antibody engineering and pharmacokinetic/pharmacodynamic modeling in the context of immunotherapies exploiting the CCP.https://doi.org/10.1002/smsc.202500149C1classical complement pathwaycomplement mediatedIgG hexamersIgG oligomerizationIgG subclasses |
| spellingShingle | Jürgen Strasser Nikolaus Frischauf Lukas Schustereder Andreas Karner Sieto Bosgra Aran F. Labrijn Frank J. Beurskens Johannes Preiner A Kinetic Model of Antigen‐Dependent IgG Oligomerization and Complement Binding Small Science C1 classical complement pathway complement mediated IgG hexamers IgG oligomerization IgG subclasses |
| title | A Kinetic Model of Antigen‐Dependent IgG Oligomerization and Complement Binding |
| title_full | A Kinetic Model of Antigen‐Dependent IgG Oligomerization and Complement Binding |
| title_fullStr | A Kinetic Model of Antigen‐Dependent IgG Oligomerization and Complement Binding |
| title_full_unstemmed | A Kinetic Model of Antigen‐Dependent IgG Oligomerization and Complement Binding |
| title_short | A Kinetic Model of Antigen‐Dependent IgG Oligomerization and Complement Binding |
| title_sort | kinetic model of antigen dependent igg oligomerization and complement binding |
| topic | C1 classical complement pathway complement mediated IgG hexamers IgG oligomerization IgG subclasses |
| url | https://doi.org/10.1002/smsc.202500149 |
| work_keys_str_mv | AT jurgenstrasser akineticmodelofantigendependentiggoligomerizationandcomplementbinding AT nikolausfrischauf akineticmodelofantigendependentiggoligomerizationandcomplementbinding AT lukasschustereder akineticmodelofantigendependentiggoligomerizationandcomplementbinding AT andreaskarner akineticmodelofantigendependentiggoligomerizationandcomplementbinding AT sietobosgra akineticmodelofantigendependentiggoligomerizationandcomplementbinding AT aranflabrijn akineticmodelofantigendependentiggoligomerizationandcomplementbinding AT frankjbeurskens akineticmodelofantigendependentiggoligomerizationandcomplementbinding AT johannespreiner akineticmodelofantigendependentiggoligomerizationandcomplementbinding AT jurgenstrasser kineticmodelofantigendependentiggoligomerizationandcomplementbinding AT nikolausfrischauf kineticmodelofantigendependentiggoligomerizationandcomplementbinding AT lukasschustereder kineticmodelofantigendependentiggoligomerizationandcomplementbinding AT andreaskarner kineticmodelofantigendependentiggoligomerizationandcomplementbinding AT sietobosgra kineticmodelofantigendependentiggoligomerizationandcomplementbinding AT aranflabrijn kineticmodelofantigendependentiggoligomerizationandcomplementbinding AT frankjbeurskens kineticmodelofantigendependentiggoligomerizationandcomplementbinding AT johannespreiner kineticmodelofantigendependentiggoligomerizationandcomplementbinding |